Klarquist Awarded Seven-Year Contract with the CDC

Published September 6, 2006

Klarquist Sparkman, LLP is pleased to announce that its patent services contract with the Centers for Disease Control and Prevention (CDC) has been renewed for another seven years. The CDC chooses two firms for patent representation, and Klarquist is proud to have represented the CDC since 2000. Klarquist welcomes the opportunity to continue to provide the CDC with the highest level of service.

The CDC functions as the world’s “immune system” by monitoring developing health problems, providing information to scientists and the public, and developing techniques to detect and prevent disease. The CDC has been at the forefront in the study of HIV, SARS, tuberculosis, infectious encephalitis, and other health threats. From its laboratories in Atlanta and throughout the global community, it continues to detect such diseases and find ways to diagnose and treat them.

Klarquist is a leading patent and intellectual property law firm in the Pacific Northwest. Klarquist has provided intellectual property legal services for more than half a century, counseling international and domestic clients in all facets of patent, trademark, trade secret, and copyright law, including litigation at the state and federal levels.